SCHEMBL6609319

SCHEMBL6609319

COc1cccc(C2NC(=O)N(C(=O)O)C(C)=C2C#N)c1

nearest known ligand 0.46

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.46
KDM4E B2RXH2 1/20 0.45
GAA P10253 1/20 0.45
HPGD P15428 1/20 0.45
MAPK1 P28482 2/20 0.44
NPSR1 Q6W5P4 1/20 0.41
USP2 O75604 1/20 0.41
L3MBTL1 Q9Y468 2/20 0.39
NR3C2 P08235 1/20 0.39
ELANE P08246 1/20 0.39
CYP2C9 P11712 1/20 0.39
HSD17B10 Q99714 1/20 0.39
TRPA1 O75762 1/20 0.39
MAPT P10636 1/20 0.38
SHMT2 P34897 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6137174 0.86 ALDH1A1 (0.44) ALDH1A1KDM4EGAAHPGDNPSR1
SCHEMBL6609236 0.85 ELANE (0.45) NPSR1ELANECYP2C9
SCHEMBL6607324 0.85 KMT2A (0.44) ALDH1A1KDM4EGAAL3MBTL1ELANE
SCHEMBL6137166 0.84 KMT2A (0.45) ALDH1A1GAAUSP2ELANECYP2C9
SCHEMBL6608283 0.84 ELANE (0.40) ALDH1A1KDM4EGAAUSP2L3MBTL1
SCHEMBL6137365 0.84 ELANE (0.40) ALDH1A1KDM4EGAAELANECYP2C9
SCHEMBL6608090 0.84 MAPK1 (0.44) ALDH1A1KDM4EMAPK1NPSR1L3MBTL1
SCHEMBL6137118 0.84 HTT (0.43) ALDH1A1HPGDELANECYP2C9MAPT
SCHEMBL6137082 0.84 TDP1 (0.50) ALDH1A1NR3C2ELANECYP2C9MAPT
SCHEMBL6137233 0.82 ELANE (0.39) ALDH1A1GAAMAPK1NPSR1USP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1373221-A4 NOVEL CYANO-SUBSTITUTED DIHYDROPYRIMIDINE COMPOUNDS AND THEIR USE TO TREAT DISEASES BRISTOL MYERS SQUIBB CO (US) 2004-09-29 EP claimed
EP-1373221-A2 NOVEL CYANO-SUBSTITUTED DIHYDROPYRIMIDINE COMPOUNDS AND THEIR USE TO TREAT DISEASES Bristol-Myers Squibb Company (US) 2004-01-02 EP claimed
WO-2002079149-A2 NOVEL CYANO-SUBSTITUTED DIHYDROPYRIMIDINE COMPOUNDS AND THEIR USE TO TREAT DISEASES BRISTOL-MYERS SQUIBB COMPANY (US) 2002-10-10 WO claimed
EP-1373221-A4 NOVEL CYANO-SUBSTITUTED DIHYDROPYRIMIDINE COMPOUNDS AND THEIR USE TO TREAT DISEASES BRISTOL MYERS SQUIBB CO (US) 2004-09-29 EP disclosed
EP-1373223-A4 CYANO-SUBSTITUTED DIHYDROPYRIMIDINE COMPOUNDS AND THEIR USE TO TREAT DISEASES BRISTOL MYERS SQUIBB CO (US) 2004-09-29 EP disclosed
EP-1373221-A2 NOVEL CYANO-SUBSTITUTED DIHYDROPYRIMIDINE COMPOUNDS AND THEIR USE TO TREAT DISEASES Bristol-Myers Squibb Company (US) 2004-01-02 EP disclosed
EP-1373223-A1 CYANO-SUBSTITUTED DIHYDROPYRIMIDINE COMPOUNDS AND THEIR USE TO TREAT DISEASES Bristol-Myers Squibb Company (US) 2004-01-02 EP disclosed
WO-2002079169-A1 CYANO-SUBSTITUTED DIHYDROPYRIMIDINE COMPOUNDS AND THEIR USE TO TREAT DISEASES BRISTOL-MYERS SQUIBB COMPANY (US) 2002-10-10 WO disclosed
WO-2002079149-A2 NOVEL CYANO-SUBSTITUTED DIHYDROPYRIMIDINE COMPOUNDS AND THEIR USE TO TREAT DISEASES BRISTOL-MYERS SQUIBB COMPANY (US) 2002-10-10 WO disclosed